Abortion Drugs & Practices

18 articles

Abortion Drugs & Practices

Six members of Indiana's congressional delegation added their names to an amicus brief to the U.S. Supreme Court in support of a Louisiana law protecting moms and babies from abortion drugs by mail. The brief reads in part: "By deregulating chemical abortion drugs and permitting them to be sent through the mail, the Biden FDA [...]

Read →
Abortion Policy, Law & Politics

WASHINGTON, DC – Today, Congressman Marlin Stutzman (IN-03) introduced the Chemical Abortion Awareness Act, which will create new requirements for communicating chemical abortion risks for providers who receive federal funds. This legislation comes on the same day as thousands of American patriots flocked to Capitol Hill to stand up for the lives of the unborn. The requirements include providing women both electronic [...]

Read →
Abortion Drugs & Practices

A letter from Indiana legislators to President Donald Trump and Vice President J.D. Vance was wired to the White House on October 29 urging immediate action on the abortion drug mifepristone and all generic versions pending “a comprehensive and transparent review of the drug’s safety data.” The letter, co-authored by Sen. Tyler Johnson and Rep. J.D. Prescott, is cosigned by Lieutenant Gov. Micah [...]

Read →
admin|Indiana Right to Life|
Abortion Drugs & Practices

INDIANAPOLIS (Oct. 3, 2025) – Indiana Right to Life President and Chief Executive Officer Mike Fichter issued this statement today regarding the U.S. Food and Drug Administration's approval of a generic version of mifepristone. "The FDA approval of a generic abortion drug will fuel illegal trafficking of abortion drugs into Indiana. "The generic version will [...]

Read →

Showing 18 of 18